EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome

Minta Kärkkäinen iD, Tero Sievänen, Tia-Marje Korhonen, Joonas Tuomikoski, Kirsi Pylvänäinen, Sami Äyrämö, Toni T Seppälä, Jukka-Pekka Mecklin, Eija K Laakkonen, Tiina Jokela

International Journal of Cancer · 01.01.2026 · 158 (1) · 243-256

DOI: 10.1002/ijc.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 26.08.2025. Verfasst von Minta Kärkkäinen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gerontology Research Center and Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Relander Foundation, Syöpäsäätiö, Päivikki ja Sakari Sohlbergin Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome is a genetic cancer‐predisposing syndrome caused by pathogenic mutations in DNA mismatch repair ( path_MMR ) genes. Due to the elevated cancer risk, novel screening methods, alongside current surveillance techniques, could enhance cancer risk stratification. Here we show how bi‐omics integration could be utilized to pinpoint potential cancer‐predicting biomarkers in Lynch syndrome. We studied which blood‐based circulating microRNAs and metabolites could predict Lynch syndrome cancer occurrence within a 5.8‐year prospective surveillance period. We used single‐ and bi‐omics bioinformatic analyses and identified omics‐level patterns and associations across these biological layers. Lasso Cox regression was used to highlight the most promising cancer‐predicting biomarkers. Our findings revealed distinct circulating metabolite landscapes among path_MMR variant carriers and a circulating microRNA co‐expression module significantly associated with future cancer incidence. These microRNAs regulate cancer‐related pathways, including the PI3K/Akt signaling pathway. Additionally, a metabolite module consisting of ApoB‐containing lipoproteins (low‐, intermediate‐, and very low‐density lipoproteins) showed distinct levels across path_MMR variants. Notably, three biomarkers— hsa‐miR‐101‐3p , hsa‐miR‐183‐5p , and triglycerides in high‐density lipoprotein particles (HDL_TG)—significantly predicted cancer risk, achieving a Harrel's Concordance Index (C‐index) of 0.76 ( p = .0007). Elevated levels of these biomarkers indicated increased cancer risk. Internal validation of the model yielded a C‐index of 0.72. The bi‐omics approach and the identified biomarkers offer promising insights for future studies regarding cancer risk identification in Lynch syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisBiomarkers, TumorHumansMicroRNAsFemaleMaleMiddle AgedProspective StudiesAdultDNA Mismatch RepairMetabolomicsMultiomics

Stichwörter der Autor:innen

Lynch syndromecancer risk predictionomics integrationsystemic biomarkers

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Gerontology Research Center and Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
  • UEF Bioinformatics Center, University of Eastern Finland, Kuopio, Finland.
  • Faculty of Information Technology, University of Jyväskylä, Jyväskylä, Finland.
  • The Wellbeing Services County of Central Finland, Jyväskylä, Finland.
  • Department NEON-S, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
  • Department of Biological and Environmental Science, Faculty of Mathematics and Science, University of Jyväskylä, Jyväskylä, Finland.

ORCID-Profile: Minta Kärkkäinen

Förderung

  • Relander Foundation
  • Syöpäsäätiö
  • Päivikki ja Sakari Sohlbergin Säätiö
  • Seppo Säynäjäkankaa's Foundation
  • K. Albin Johanssons Stiftelse
  • Suomen Lääketieteen Säätiö
  • Eemil Aaltonen Foundation
  • Jane ja Aatos Erkon Säätiö

Zitieren

APA

Kärkkäinen, M., Sievänen, T., Korhonen, T. M., Tuomikoski, J., Pylvänäinen, K., Äyrämö, S., Seppälä, T. T., Mecklin, J. P., Laakkonen, E. K., & Jokela, T. (2026). Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome. International Journal of Cancer, 158(1), 243-256. https://doi.org/10.1002/ijc.70106

Vancouver

Kärkkäinen M, Sievänen T, Korhonen TM, Tuomikoski J, Pylvänäinen K, Äyrämö S, et al. Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome. International Journal of Cancer. 2026;158(1):243-256. doi:10.1002/ijc.70106

BibTeX
@article{Krkkinen2026,
  author = {Kärkkäinen, Minta and Sievänen, Tero and Korhonen, Tia-Marje and Tuomikoski, Joonas and Pylvänäinen, Kirsi and Äyrämö, Sami and Seppälä, Toni T and Mecklin, Jukka-Pekka and Laakkonen, Eija K and Jokela, Tiina},
  title = {Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {158},
  number = {1},
  pages = {243--256},
  doi = {10.1002/ijc.70106}
}
Kostenlos starten →